0001096906-22-002328.txt : 20220923 0001096906-22-002328.hdr.sgml : 20220923 20220923161402 ACCESSION NUMBER: 0001096906-22-002328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 FILED AS OF DATE: 20220923 DATE AS OF CHANGE: 20220923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUEMOELLER JOHN WALTER II CENTRAL INDEX KEY: 0001568485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 221262494 MAIL ADDRESS: STREET 1: 305 SAN ANSELMO AVENUE STREET 2: SUITE 300 CITY: SAN ANSELMO STATE: CA ZIP: 94960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-03-19 0 0001514946 AXIM BIOTECHNOLOGIES, INC. AXIM 0001568485 HUEMOELLER JOHN WALTER II 6191 CORNERSTONE COURT, E. SUITE 114 SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer Common Stock 2020-03-19 4 P 0 6000000.0000 A 6000000.0000 D Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer. /s/ John W. Huemoeller II 2022-09-23